Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Prognostic Value by Molecular Analysis in Paediatric Osteosarcomas of the Chromosomal Regions Containing Rb, p16, p53, Cycline D1, APC, erbB2 and C-met Genes

NCT00223184 is registered in ClinicalTrials.gov with University Hospital, Strasbourg, France as lead sponsor.

NCT NCT00223184
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00223184 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Prognostic Value by Molecular Analysis in Paediatric Osteosarcomas of the Chromosomal Regions Containing Rb, p16, p53, Cycline D1, APC, erbB2 and C-met Genes
Lead sponsor
University Hospital, Strasbourg, France
Phase
Observational
Overall status
Completed
Start date
March 31, 2003
Completion date
August 31, 2011
Enrollment
Not reported
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

paediatric osteosarcomas